# VASOPRESSIN
> **ANDA211857** · Abbreviated New Drug Application (Generic) · Sponsor: AMPHASTAR PHARMS INC · Approved 2022-07-18
## Drug
- **FDA Application Number:** ANDA211857
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VASOPRESSIN
- **Generic name:** VASOPRESSIN
- **Active ingredients:** VASOPRESSIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AMPHASTAR PHARMS INC
- **Manufacturer:** Amphastar Pharmaceuticals, Inc.
- **First approval:** 2022-07-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211857)
---
*AI Analytics · CC0 1.0*